Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin

Pharmacogenetics of Oxaliplatin as Adjuvant Treatment in Colon Carcinoma

(2012) Arantza Fariña Sarasqueta et al.   Molecular Diagnosis & Therapy

Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX®Colon Cancer Assay

(2011) Kim M Clark-Langone et al.   BMC CANCER

Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?

(2011) Robin K. Kelley et al.   Clinical Colorectal Cancer

Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity

(2011) Paulo M. Hoff et al.   Clinical Colorectal Cancer

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

(2011) Greg Yothers et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

(2011) Richard G. Gray et al.   JOURNAL OF CLINICAL ONCOLOGY

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

(2011) Daniel G. Haller et al.   JOURNAL OF CLINICAL ONCOLOGY

DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

(2011) F. A. Sinicrope et al.   JNCI-Journal of the National Cancer Institute

Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility

(2011) S. B. Park et al.   ONCOLOGIST

Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer

(2011) Niels Frank Jensen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Oxaliplatin-Induced Neuropathy in Colorectal Cancer

(2011) Andrew Weickhardt et al.   Journal of Oncology

Long-Term Survival Results of Surgery Alone Versus Surgery Plus 5-Fluorouracil and Leucovorin for Stage II and Stage III Colon Cancer: Pooled Analysis of NSABP C-01 Through C-05. A Baseline from Which to Compare Modern Adjuvant Trials

(2010) Neal W. Wilkinson et al.   ANNALS OF SURGICAL ONCOLOGY

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

(2010) Michael J. O'Connell et al.   JOURNAL OF CLINICAL ONCOLOGY

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

(2010) Daniel J. Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Functional Genomics Reveals Diverse Cellular Processes That Modulate Tumor Cell Response to Oxaliplatin

(2010) K. A. Harradine et al.   MOLECULAR CANCER RESEARCH

Balancing the efficacy and toxicity of chemotherapy in colorectal cancer

(2010) Michael S. Braun et al.   Therapeutic Advances in Medical Oncology

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Palliative Care and Oncology: Growing Better Together

(2008) Ira Byock   JOURNAL OF CLINICAL ONCOLOGY